Minireviews Open Access
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jan 27, 2021; 13(1): 7-18
Published online Jan 27, 2021. doi: 10.4240/wjgs.v13.i1.7
Role of artificial intelligence in hepatobiliary and pancreatic surgery
Hassaan Bari, Bobby V M Dasari, Department of HPB and Liver Transplantation Surgery, Queen Elizabeth Hospital, Birmingham B15 2TH, United Kingdom
Sharan Wadhwani, Department of Radiology, Queen Elizabeth Hospital, Birmingham B15 2TH, United Kingdom
ORCID number: Hassaan Bari (0000-0001-7098-6942); Sharan Wadhwani (0000-0002-1440-9179); Bobby V M Dasari (0000-0003-2375-1141).
Author contributions: Dasari BVM designed the study; Bari H and Dasari BVM performed the literature search and analyzed the literature; Dasari BVM and Wadhwani S provided expert input; Bari H, Dasari BVM and Wadhwani S wrote the manuscript; all authors have read and approve the final manuscript.
Conflict-of-interest statement: There are no conflicts of interest to declare from all the three authors.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bobby V M Dasari, MS, FRCS, Surgeon, Consultant HPB and Liver Transplant Surgeon, Department of Liver Surgery, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, United Kingdom. bobby.dasari@uhb.nhs.uk
Received: October 28, 2020
Peer-review started: October 28, 2020
First decision: November 30, 2020
Revised: December 8, 2020
Accepted: December 17, 2020
Article in press: December 17, 2020
Published online: January 27, 2021
Processing time: 77 Days and 19.8 Hours

Abstract

Over the past decade, enhanced preoperative imaging and visualization, improved delineation of the complex anatomical structures of the liver and pancreas, and intra-operative technological advances have helped deliver the liver and pancreatic surgery with increased safety and better postoperative outcomes. Artificial intelligence (AI) has a major role to play in 3D visualization, virtual simulation, augmented reality that helps in the training of surgeons and the future delivery of conventional, laparoscopic, and robotic hepatobiliary and pancreatic (HPB) surgery; artificial neural networks and machine learning has the potential to revolutionize individualized patient care during the preoperative imaging, and postoperative surveillance. In this paper, we reviewed the existing evidence and outlined the potential for applying AI in the perioperative care of patients undergoing HPB surgery.

Key Words: Artificial intelligence; Liver surgery; Pancreatic surgery; Augmented reality; Virtual reality; Intra-operative

Core Tip: The use of artificial intelligence (AI) increases hepatobiliary surgeons' capability in the timely selection of appropriate patients for precise, personalized delivery of complex surgical procedures with increased safety and ease. Published studies have mainly concentrated on assessing the technical feasibility of utilizing AI, and future research needs to focus on delivering and assessing the clinical impact of these promising techniques.



INTRODUCTION

Outcomes of hepatobiliary and pancreatic (HPB) surgery have improved tremendously over the past decade with reduced postoperative mortality from 20% to less than 3% and 5%-6% for major liver and pancreatic surgery, respectively[1,2]. Such an improvement has been attributed to more sophisticated preoperative imaging and improved perioperative care, progressive surgical techniques with a better anatomical understanding of anatomy, technological advancement of intra-operative instrumentation, early identification, and management of complications[3,4]. However, procedures remain technically complex, requiring careful preoperative planning, intra-operative execution from experienced surgeons, anesthetists, nursing staff, and longer operative hours. The postoperative morbidity remains high at 20%-30%, and mortality rates for some of the more complex resections is reported to be as high as 10%[5-8]. There is a need to continue to explore and integrate the novel and innovative technological tools into the clinical practice to improve these outcomes.

Artificial Intelligence (AI) has been investigated for its role in predictive population risk stratification, clinical decision support systems, promoting it into the new era of digital medicine, and precise surgery[9-12]. Most of the uses of AI are based on machine learning, which is a technique that can automatically learn, recognize specific patterns, and make useful decisions based on the available data[13]. Deep learning is part of the same technique, which replicates the neural network of the human brain for data analysis. The most representative characteristic of deep learning is that it is based on actual data, and the decision process is accomplished with minimal human interventions[14,15]. Integration of such processes into the various aspects of delivery of HPB surgery will allow improving oncological and post-operative outcomes.

In this article, we review the existing and the future role of AI in HPB surgery by focusing on (1) preoperative planning [three-dimensional (3D) visualization and printing]; (2) intra-operative care; integrated use of augmented reality in open and minimally invasive (laparoscopic and robotic) surgery; and (3) finally its application in postoperative care and radiomics (Table 1).

Table 1 Summary of the studies included in the review evaluating the role of artificial intelligence in hepatobiliary and pancreatic surgery.
Ref.
Aim
No. of patients
Outcome
Preoperative imaging
Fang et al[18]To compare the surgical outcomes of pre-operative planning based on 3D assisted surgery for HCC116Shorter operation time (P = 0.028), and reduced complications (P = 0.048) among surgeries performed based on 3D planning
Mise et al[30]To assess how pre-operative VH influences the outcomes of liver surgery1194Better post-operative oncological outcomes for those in the VH group (P = 0.04)
Fang et al[33]To assess the resectability of pancreatic and periampullary tumours by 3D visualization system80PPV, NPV, sensitivity, specificity, accuracy for resectability was 100% and was better than CT angiography (P < 0.05)
Intra-operative use
Okamoto et al[46]To evaluate the utility of AR-based navigation surgery for pancreatectomy19Surface-rendering image corresponded to that of the actual organ
Allowed safe dissection while preserving the adjacent vessels or organs
Ntourakis et al[49]To investigate the potential of AR-based navigation to help locate and resect colorectal liver metastases03Allowed detection of all the lesions
Buchs et al[65]To evaluate Stereotactic navigation technology for targeting hepatic tumors during robotic liver surgery02The augmented endoscopic view allows accurate assessment of resection margin and allowed better identification of vascular and biliary structures during parenchymal transection
Post-operative management and follow-up
Merath et al[71]To assess ML algorithm to predict patient risk of developing complications following liver, pancreatic or colorectal surgery15, 657Good predictability of post-operative complication with C-statistic of 0.74, outperforming the ASA (0.58) and ACS-surgical risk (0.71) calculators
Mai et al[73]To establish and validate an ANN model to predict severe PHLF in patients with HCC following hemi hepatectomy357The ANN model resulted in AUROC of 0.880 for the development set of and 0.876 for the validation set in predicting severe PHLF
Zhou et al[80]To develop a CT-based radiomic signature and assess its ability to preoperatively predict the early recurrence of HCC215Adding a radiomics signature into conventional clinical variables can significantly improve the accuracy of the preoperative model in predicting early recurrence (P = 0.01)
Banerjee et al[82]RVI was assessed for its ability to predict MVI and outcomes in patients with HCC who underwent surgical resection or liver transplantThe diagnostic accuracy, sensitivity, and specificity of RVI in predicting MVI was 89%, 76% and 94%, respectively. Positive RVI score was associated with lower OS (P < 0.001) and RFS (P = 0.001)
AI-BASED PREOPERATIVE IMAGING
3D visualisation and virtual simulation

Currently, most HPB surgeons use two-dimensional (2D) images from computed tomography (CT), magnetic resonance imaging (MRI) scans to evaluate the position of a lesion, and its relationship to the surrounding structures in the preoperative planning. However, the 3D cognitive interpretation of spatial structure of the tumor and its relation with surrounding structures can be misjudged at times. Professor Marescaux[16] was the first to use 3D visualization to delineate the complex liver anatomy in 1998. 3D reconstruction of 2D images from CT scan and MRI helps the surgeon to visualize the spatial relationship of the tumor and surrounding intrahepatic structures, identify the normal vascular and biliary anatomy and its variations, and ultimately improves preoperative planning and at times to be able to consider surgical resection based on 3D imaging in patients considered unresectable on 2D images or vice versa[17-19]. Fang et al[18,20] demonstrated that patients who underwent surgery based on a 3D operation plan had lesser operation time (P = 0.028), lower hepatic inflow occlusion (P = 0.029), and reduced high grade (Clavien-Dindo grade III-V) postoperative complications (P = 0.048) as compared to patients who underwent surgery without any 3D planning[18,20].

Hilar cholangiocarcinoma usually presents in an advanced stage when the caudate lobe and hilar structures are already invaded[21]. These patients require radical resection with hepatectomy, associated with significantly increased mortality of 10%-15% and a significantly higher postoperative morbidity of up to 40%[22,23]. Zhang et al[24] in a study of 23 patients with hilar cholangiocarcinoma of Bismuth grades III and IV, showed that preoperative 3D reconstruction could accurately determine the presence of tumor invasion into hilar vessels, variant hilar anatomy, and future liver volumes that helped to develop an individualized operative plan for a patient[24]. Similar benefits were reported by Okuda et al[25] along with higher negative resection margins for biliary malignancies for patients who underwent preoperative surgical planning with 3D reconstruction[25]. Another benefit of 3D reconstruction is the accurate stereoscopic assessment of portal vein anatomy and determining the line of parenchymal transection and planning portal vein reconstruction[26]. Other studies also reported similar benefits including reduced amount of intraoperative bleeding with the use of preoperative 3D reconstruction[27-29].

3D visualization techniques are also used to perform virtual liver resection before actual surgery to assess the resectability of the lesion and calculate future liver remnant. In patients with hepatocellular carcinoma (HCC), virtual hepatectomy allowed more aggressive surgery based on portal territory–oriented resection with a higher disease-free 5-year survival. Similarly, patients with colorectal liver metastasis (CRLM) who underwent virtual hepatectomy had equivalent long term outcomes to patients who did not have a virtual resection, despite the larger tumor load in the virtual hepatectomy group[30]. Virtual hepatectomy is also of great use in living donor liver transplantation procedures. The donor selection can be further optimized based on the information available from 3D imaging, including the need for venous reconstruction based on the donor vascular anatomy resulting in improved safety of operation[30].

3D visualization of peri-pancreatic vessels before surgery is reported to have reduced the operative time, blood loss, and hospital stay significantly compared to patients who underwent surgery based on 2D image planning prior to pancreaticoduodenectomy (P = 0.024) and distal pancreatectomy (P = 0.026)[31,32]. Fang et al[33] reported sensitivity and sensitivity of 100% for resectability assessment of pancreatic cancer by 3D reconstruction[33]. It also helps determine the size and location of the main pancreatic duct before surgery, which may help select optimal anastomotic technique[31]. Assessment of resectability of the borderline resectable tumors (with involvement of surrounding vessels) is vital as 25% of the patients explored surgically are considered unresectable at laparotomy. It is likely that the benefits of 3D reconstruction be translated to improve the resection rates in this group.

3D printed models

Although 3D images and reconstruction can significantly benefit the understanding the surgical anatomy, the display is still on 2D screen, limiting its use. This limitation can be overcome by converting 3D reconstructed images into real physical models with 3D printing technology. The first use of 3D printing was reported in 2013 by Zein et al[34]. Since then, 3D printing has been reported to be useful in treating liver tumors and also in liver transplants[35-39]. One substantial benefit of the 3D printed model is that they can be brought into the operating room and compared with the real liver during surgery and adjusted in the optimal anatomical position to identify intrahepatic structures. This advantage of navigating on a real physical liver model is that it can locate small, disappearing CRLM and perform precise segmentectomies. 3D-printed models allow visualization and planning of the exact line of transection[36,39]. Xiang et al[26] reported the ability to precisely identify and manage the replaced hepatic arteries, segment IV portal vein branch coming from the right anterior portal vein to plan a right hemihepatectomy with extreme precision and prevent segment IV ischemia in a patient with HCC and avoided post hepatectomy decompensation of the liver function[26]. Burdall et al[38] reported using a hybrid 3D model containing hepatic, pancreatic, and choledochal components and used it to simulate laparoscopic choledochal surgery[38]. In living donor liver transplantation for small infants and neonates, 3D printed liver models have shown promising results in assessing the size discrepancies between recipient and graft[39]. Such information is useful for an adequate plan to reduce the graft volume and complex vascular and biliary structures of the liver than traditional CT imaging and help avoid unexpected surgical complications while preserving the vital vascular structures[39]. However, such a comparison of the real-time and printed models will need 1:1 size matching increasing the production cost of each model.

Low-cost 3D liver printed models were used for trainees' medical education and to help them practice hepatectomy operations with a positive impact on the understanding of liver anatomy, better visualization, and higher learning efficacy[40,41]. The recent 3D Bio-printed models consist of new-generation bio-inks and hepatic cells, which are biocompatible, scalable, convenient, and low-cost[42]. These models have a vital role in developing liver tissue engineering and even artificial liver, which may expand their therapeutic role in managing patients with liver failure[42].

AI can reduce the complexity of a traditionally manual process of 3D printing. The main application of AI in 3D printing comes from automation of workflow. This comprises various steps, from the creation of the model as a Computer Aided Design file, to its preparation for printing in a slicing software, to its final printing. AI can also help improve the 3D printing process by assessing the printability before starting any process. The quality of the final product can also be predicted and the process be controlled to avoid printing errors, effectively saving time.

Intraoperative use of AI in HPB surgery

The major drawback of 3D reconstruction and printing techniques lies in associating the 3D reconstructed images or physical models to the actual surgery due to inadequate synchronization between the two modalities[43]. These limitations could be overcome using computer guiding software, which combines preoperative 3D reconstructive images with intraoperative information in real-time. It can be done by Augmented Virtuality (AV) that displays a virtual environment that is controlled by real information or by Augmented Reality (AR) that displays virtual information based on real images of the patient. It is a relatively new and unused tool to improve oncological safety in the field of HPB surgery. It can confirm the ideal dissection plane and anatomical landmarks in real-time and help achieve safe margins with maximum functional preservation[44]. AV, AR, and mixed reality (MR) offer a safe and reliable surgical navigation method, which reduces the chances of misinterpretation between the 3D reconstruction model and actual operating space[30,44].

For locally advanced pancreatic cancers, intraoperative computer-based navigation can be used to assess the spatial relationship of the tumor with the involved vessels and the possibility of venous reconstruction or arterial involvement depending on tumor invasion, increasing the safety, and effectiveness of the procedure[45]. Okamoto et al[46] reported 19 patients who underwent AR-based navigation surgery for pancreatectomy[46]. In this study, reconstructed preoperative images were superimposed on the real organs on the monitor display during surgery, and it corresponded to that of the actual organs[46]. Such information is most useful in patients with small pancreatic neuroendocrine tumours, liver lesions deep in the parenchyma that are challenging to navigate at minimally invasive surgery, and planning of microwave coagulation therapy[47-49]. Modern chemotherapy for CRLM can cause shrinkage of tumors to the extent that they may disappear on post-chemotherapy scans. In a pilot study, Ntourakis et al[49] reported that AR helped in detecting those missing lesions and achieving a negative margin with no local recurrence at a median follow up of 22 mo[49].

AI in minimally invasive HPB surgery

Laparoscopic cholecystectomy is one of the most common general and specialist surgical procedures performed worldwide. Injury to common bile duct is considered one of the avoidable complications that is otherwise associated with the need for further interventions and adds a considerable burden of medico-legal litigation. The risk of bile duct injury can be reduced by correctly identifying the standard anatomical landmarks at surgery (the common bile duct, cystic duct, lower edge of the left medial liver segment, Rouviere's sulcus). Tokuyasu et al[50] developed an AI-based learning model to detect these four anatomical landmarks using real-time object detection algorithms on using a training set of over 2000 endoscopic camera images[50]. These landmarks were successfully identified with adequate precision intra-operatively by the validation cohort, and such novel systems can reduce bile duct injury during laparoscopic cholecystectomy and other iatrogenic injuries[50].

Minimally invasive surgery for major laparoscopic hepatectomies is being practiced routinely in specialist units with reported benefits of reduced scar size, postoperative morbidity, and shorter hospital stay[51]. Donor hepatectomy, pancreaticoduodenectomy are also increasingly performed by experienced specialist surgeons by minimally invasive means. However, in addition to the long learning curve for the surgeons to be able to perform these procedures, one of the main issues is the loss of the tactile sensation, which is replaced by force feedback through a laparoscopic instrument to differentiate between the tissues of varying consistency, making it challenging to appreciate tumor margins and be able to identify the smaller but vital vascular structures.

For minimally invasive surgeries, it seems appropriate to use AR techniques to superimpose in the endoscopic view structures which are not visible by direct camera view but are visible in the preoperative images[52,53]. AR technology uses CT and MRI data to reconstruct a 3D image of the liver and detailed intrahepatic vasculature, and the virtual image is superimposed on the liver surface in a 1:1 ratio, to assist the operating surgeon during surgery[53,54]. Phutane et al[55] showed that AR-based hepatectomy for HCC could help detect intrahepatic tumors, the transection plane, and locating the hepatic veins before parenchymal transection, which can reduce bleeding and duration of surgery[55]. Similar findings were reported by Hallet et al[56] who used tans-thoracic minimally invasive liver resection guided by AR[56].

Loss of depth perception with monocular cameras is also another disadvantage contributing to the longer operative times[57,58]. These limitations could potentially be overcome with the help of AR and MR technology, which will not only aid in finding the position the intra-parenchymal lesions but also provides a better field of vision. This facilitates the oncological resection and limits the risk of operative bleeding[30,59]. It also provides a solution to reduce the gap between the three-dimensional recon-struction model and the actual operating space, which helps overcome uncoordi-nated hand and eye maneuvering during surgery[43,54].

AR also has a vital role in laparoscopic surgical education of trainees. For surgeons in the earlier part of the career, this could reduce the duration of learning curves. A recent randomized controlled trial showed that AR-based training could improve the necessary skills of laparoscopic cholecystectomy in surgical residents and overcome the learning curve[60]. It has distinct advantages and broad prospects in many aspects, such as preoperative planning, intraoperative navigation, surgical education, and doctor-patient communication[54]. Although 3D visualization and AR allow further navigation, there is still a need to develop more on the haptics to replace the palpation, and tactile sensation in minimally invasive HPB surgery, may it be to determine the boundaries between normal and cancer tissue.

The limitations include that the patient-specific 3D reconstructed images need to be prepared using complex algorithms requiring a lot of time and effort. This problem can be overcome by real-time acquisition of high-resolution preoperative scans and 3D reconstructions. Secondly, preparing the whole system to achieve the desired navigation during surgery and required registrations; the process itself can significantly increase the overall duration of surgery and anesthesia time for patients. It varies on the type of procedure and the complexity of the AR system as well. The solution to this problem is to develop fully automated systems, which would reduce the total time required for completion. However, to date, most of the registration is performed manually.

Robotic HPB surgery

The use of AI techniques in HPB robotic surgery helps achieve exceptional performance with increased ability to perform the fine skills in delineating complex in vivo hilar and pancreatic anatomy, helping the operating surgeon make accurate decisions and perform the desired task with increased meticulousness and efficiency[12]. 3D imaging, multi-fold magnification, and significantly improved dexterity are the most noticeable features of currently available robotic systems that allow precise tumor localization, dissection, reduce blood loss, and potentially higher success rates for certain types of hepatobiliary procedures like spleen-preserving distal pancreatectomies compared to a traditional open approach[61]. 10-fold magnified 3D intra-operative views of robotic surgery overcome the limitation of depth perception associated with the laparoscopic technique. It helps in the dissection of delicate tissue like liver parenchyma, and the increased dexterity, even in narrow spaces, allows for intra-corporeal suturing at the same time[62]. This was highlighted in a matched comparative study in which higher rates of successful, purely minimally invasive approaches were reported with the robotic technique compared with conventional laparoscopy for major hepatectomies[63]. As with laparoscopy, the surgeon operating with the help of a robot cannot use the "sense of touch" to identify blood vessels or differentiate between healthy and scar tissue by manual palpation.

AR has been used to overcome this limitation[58]. Pessaux et al[64] reported the use of the see-through visualization feature of AR for port placement, one of the most crucial steps in robotic surgery. Each robotic port was placed according to the patient's anatomy, variations, and target lesions. AR allowed for the accurate and safe identification of intrahepatic vascular structures throughout the surgery. Hepatic pedicle clamping was not used in any of the cases, and none of the patients required perioperative transfusion[64]. In another study, Buchs et al[65] reported the benefits of AR-based robotic resection in patients who had resection of HCC. The augmented endoscopic view delineated an accurate resection margin around the tumor. The overlay of reconstructed 3D models also helped during parenchymal transection to identify vascular and biliary structures, and safe tumor margin widths of 0.5 cm and 1 cm were achieved, with no complications[65]. Constant research and development have also enabled robots to automatically perform some in vitro simple surgical errands, such as suturing and knot tying[66]. However, the current equipment and technology are still far from attaining complete autonomy to robots in surgery, and human control would continue for safety and complex decision-making.

Regarding intraoperative limitations, inattentional blindness, an event when an unexpected object suddenly appears in the surgeons' field of view, is one of the biggest concerns that need to be addressed while using 3D overlays[67]. AR provides a vast amount of data and information to surgeons, which may be distracting[68]. Therefore, it is of utmost importance to project only relevant data or develop a method to display different sets of information depending on surgeons' needs. The latency of the whole system of AR is also a concern. Currently, the latency for laparoscopic procedures is reported to be 144 ± 19 milliseconds[69], and any prolonged latency in robotic surgery is best avoided to maintain the accuracy and the surgeon's comfort.

PREDICTIVE MODEL GUIDED POSTOPERATIVE MANAGEMENT
Predictive models for postoperative morbidity

HPB surgery is associated with high postoperative morbidity and mortality rates. The reported morbidity rate for major hepatectomy is 25%, and for pancreatico-duodenectomy, it is nearly 40%[5-8,70]. Early prediction of morbidity with detailed attention and thorough postoperative management of complications can positively impact the overall outcomes of complex HPB procedures. The perioperative imaging information can be combined with clinical data to establish corresponding diagnostic and predictive models. For instance, a machine learning technique was applied to develop an algorithm after extracting data of 15657 patients was used to predict the postoperative morbidity after HPB and colorectal surgery[71]. This algorithm had a better predictive (C-statistic of 0.74) ability than other established methods like the American College of Surgery-risk calculator (C-statistic 0.71) and American Society of Anaesthesiologists levels (C-statistic 0.58). The algorithm had excellent performance in predicting postoperative stroke, wound dehiscence (superficial SSI, organ space SSI), cardiac arrest, and progressive renal failure (C-statistic 0.96-0.98). The algorithm also showed a good predictive ability for sepsis and perioperative hemorrhage[71]. Similarly, algorithms are being used to predict the risk of liver failure after hepatectomy[72,73]. Patients at risk of liver failure may avoid major hepatectomy and undergo adjuvant or an alternative treatment.

Predictive models for a liver transplant

In liver transplant, data that predicts the expected survival with a specific graft is crucial in selecting the best recipient for each graft. Wingfield et al[74] in a systematic review suggested that AI based predictive model can be used to determine graft outcomes after deceased donor liver transplant. These models were based on multiple factors from donor, recipient, and graft. The AI-based models proved to be superior in predicting graft survival than the traditional log regression model and other classic scores (MELD, SOFT)[74]. Similar findings were reported by Liu et al[75] when they developed a machine learning-based algorithm to predict short term survival after liver transplant[75]. These models can be used to assign the graft to appropriate recipients and improve survival and the outcomes after liver transplant.

Radiomics in HPB surgery and models for cancer surveillance

Radiomics presents a new horizon to generate new understanding and concepts within specific areas of pathology. It is based on the techniques which mines quantitative data from patients imaging (Ultrasound, CT, MRI, and PET/CT) and analyses it to retrieve clinically relevant information that can be used for diagnosis and prognostication[76]. For example, Park et al[77] recently developed a radiomics fibrosis index to assess liver cirrhosis[77]. The model was based on data extracted from MRI images of the liver. This radiomics index demonstrated to be considerably better than routine normalized liver enhancement and serum fibrosis indices[77]. A similar CT based radiomic model was used for the diagnosis and severity of portal hypertension. This model was significantly better in diagnosing portal hypertension than clinical indices and other methods like liver stiffness[78].

The role of radiomics is getting significantly crucial in the field of hepatobiliary oncology. The role is postulated on the theory that a radiologic phenotype can imitate genetic variations of carcinogenesis and help determine the expected tumour behavior. These radiomics based models are being used to substantiate clinical decision making and practice precision medicine. Hepatocellular carcinoma is associated with a high recurrence rate. Early recurrence after resection is itself a poor prognostic factor, reducing 5-year survival rates from 70% to 30%[79]. Almost 50% of patients develop recurrence within five years of surgery. If patients at increased risk of recurrence are identified using accurate algorithms, the physician can arrange more close surveillance. Zhou et al[80] developed a model based on 21 radiomic features from 300 patients[80]. This model proved that combining conventional clinical factors and radiomics feature can perform better in accurately predicting early recurrence than with Barcelona Clinic Liver Cancer (BCLC) staging, Childs classification, and other clinical features alone[80]. Microvascular invasion is one of the indicators of early recurrence in patients with HCC[81]. This information is often available only on post-resection histological analysis. Banerjee et al[82] developed a model based on a cluster of preoperative radiomic features for predicting the presence of microvascular invasion[82]. Its accuracy can reach up to 94%, which is better than the results based on imaging only[82]. Zheng et al[83] developed a CT–based radiomic normogram to predict recurrence-free survival rates for HCC after resection, ablation, and transplant. These normograms predicted the prognosis and recurrence much more effectively than the traditional staging[83].

Elarre et al[84] evaluated the 2-year relapse risk for pancreatic cancer patients based on a machine-learning algorithm[84]. The main goal was to provide prognostic information to patients who underwent pancreatic resection. This model showed an accuracy of more than 60% for disease recurrence within two years of surgery[84]. It proved to be a valuable tool, especially for high-risk patients. Intensive surveillance and extended use of adjuvant treatment for such patients can be considered based on this model[84].

CONCLUSION

The ultimate goal of AI is to achieve a better and individualized healthcare plan for each patient. Integrating the genomic and molecular targeting information and clinic-pathological features of the individual liver and pancreatic cancer patients will enable surgeons to provide precise and personalized surgery with the aid of surgical technology enhanced with 3D imaging, AR, VR and MR modalities.

Footnotes

Manuscript source: Invited manuscript

Specialty type: Gastroenterology and hepatology

Country/Territory of origin: United Kingdom

Peer-review report’s scientific quality classification

Grade A (Excellent): 0

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): 0

Grade E (Poor): 0

P-Reviewer: Jiang C S-Editor: Fan JR L-Editor: A P-Editor: Wu YXJ

References
1.  Ahola R, Siiki A, Vasama K, Vornanen M, Sand J, Laukkarinen J. Effect of centralization on long-term survival after resection of pancreatic ductal adenocarcinoma. Br J Surg. 2017;104:1532-1538.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 46]  [Article Influence: 6.6]  [Reference Citation Analysis (1)]
2.  Filmann N, Walter D, Schadde E, Bruns C, Keck T, Lang H, Oldhafer K, Schlitt HJ, Schön MR, Herrmann E, Bechstein WO, Schnitzbauer AA. Mortality after liver surgery in Germany. Br J Surg. 2019;106:1523-1529.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 70]  [Cited by in F6Publishing: 73]  [Article Influence: 14.6]  [Reference Citation Analysis (0)]
3.  Yamazaki S, Takayama T. Management strategies to minimize mortality in liver resection for hepatocellular carcinoma. Jpn J Clin Oncol. 2017;47:899-908.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
4.  Bhandari S, Abdul MKM, Hollabaugh W, Sharma K, Evans DB, Guda N. Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions. PLoS One. 2018;13:e0199909.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 8]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
5.  Lermite E, Sommacale D, Piardi T, Arnaud JP, Sauvanet A, Dejong CH, Pessaux P. Complications after pancreatic resection: diagnosis, prevention and management. Clin Res Hepatol Gastroenterol. 2013;37:230-239.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 69]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
6.  Franken LC, Schreuder AM, Roos E, van Dieren S, Busch OR, Besselink MG, van Gulik TM. Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis. Surgery. 2019;165:918-928.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 70]  [Article Influence: 14.0]  [Reference Citation Analysis (0)]
7.  Kingham TP, Correa-Gallego C, D'Angelica MI, Gönen M, DeMatteo RP, Fong Y, Allen PJ, Blumgart LH, Jarnagin WR. Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy. J Am Coll Surg. 2015;220:471-479.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 111]  [Cited by in F6Publishing: 118]  [Article Influence: 11.8]  [Reference Citation Analysis (0)]
8.  Wiggers JK, Groot Koerkamp B, Cieslak KP, Doussot A, van Klaveren D, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Gouma DJ, Kingham TP, van Gulik TM, Jarnagin WR. Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. J Am Coll Surg 2016; 223: 321-331. e1.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 118]  [Cited by in F6Publishing: 142]  [Article Influence: 17.8]  [Reference Citation Analysis (0)]
9.  Ye JJ. Artificial Intelligence for Pathologists Is Not Near--It Is Here: Description of a Prototype That Can Transform How We Practice Pathology Tomorrow. Arch Pathol Lab Med. 2015;139:929-935.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 20]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
10.  Chilamkurthy S, Ghosh R, Tanamala S, Biviji M, Campeau NG, Venugopal VK, Mahajan V, Rao P, Warier P. Deep learning algorithms for detection of critical findings in head CT scans: a retrospective study. Lancet. 2018;392:2388-2396.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 443]  [Cited by in F6Publishing: 452]  [Article Influence: 75.3]  [Reference Citation Analysis (0)]
11.  Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44-56.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2376]  [Cited by in F6Publishing: 2256]  [Article Influence: 451.2]  [Reference Citation Analysis (0)]
12.  Mirnezami R, Ahmed A. Surgery 3.0, artificial intelligence and the next-generation surgeon. Br J Surg. 2018;105:463-465.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 37]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
13.  Krizhevsky A, Sutskever I, E.   Hinton G, editors. Imagenet classification with deep convolutional neural networks. The twenty-sixth annual conference on neural information processing systems (NIPS); 2012 Dec 3-8; Nevada, United States. Advances in neural information processing systems 2012: 1097-1105.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Khosravi P, Kazemi E, Imielinski M, Elemento O, Hajirasouliha I. Deep Convolutional Neural Networks Enable Discrimination of Heterogeneous Digital Pathology Images. EBioMedicine. 2018;27:317-328.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 230]  [Cited by in F6Publishing: 176]  [Article Influence: 29.3]  [Reference Citation Analysis (0)]
15.  Litjens G, Kooi T, Bejnordi BE, Setio AAA, Ciompi F, Ghafoorian M, van der Laak JAWM, van Ginneken B, Sánchez CI. A survey on deep learning in medical image analysis. Med Image Anal. 2017;42:60-88.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5573]  [Cited by in F6Publishing: 4406]  [Article Influence: 629.4]  [Reference Citation Analysis (0)]
16.  Marescaux J, Clément JM, Tassetti V, Koehl C, Cotin S, Russier Y, Mutter D, Delingette H, Ayache N. Virtual reality applied to hepatic surgery simulation: the next revolution. Ann Surg. 1998;228:627-634.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 183]  [Cited by in F6Publishing: 131]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
17.  Fang CH, LauWan YY, Cai W. [The present status and future prospects of application of digital medical technology in general surgery in China]. Zhonghua Waike Zazhi. 2017;55:11-14.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
18.  Fang CH, Tao HS, Yang J, Fang ZS, Cai W, Liu J, Fan YF. Impact of three-dimensional reconstruction technique in the operation planning of centrally located hepatocellular carcinoma. J Am Coll Surg. 2015;220:28-37.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 59]  [Article Influence: 5.9]  [Reference Citation Analysis (1)]
19.  Hu M, Hu H, Cai W, Mo Z, Xiang N, Yang J, Fang C. The Safety and Feasibility of Three-Dimensional Visualization Technology Assisted Right Posterior Lobe Allied with Part of V and VIII Sectionectomy for Right Hepatic Malignancy Therapy. J Laparoendosc Adv Surg Tech A. 2018;28:586-594.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 11]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
20.  Fang CH, Liu J, Fan YF, Yang J, Xiang N, Zeng N. Outcomes of hepatectomy for hepatolithiasis based on 3-dimensional reconstruction technique. J Am Coll Surg. 2013;217:280-288.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 37]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
21.  Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14:535-543; discussion 544.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 336]  [Cited by in F6Publishing: 313]  [Article Influence: 9.2]  [Reference Citation Analysis (0)]
22.  Kimura N, Young AL, Toyoki Y, Wyatt JI, Toogood GJ, Hidalgo E, Prasad KR, Kudo D, Ishido K, Hakamada K, Lodge JPA. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Surgery. 2017;162:500-514.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 50]  [Article Influence: 7.1]  [Reference Citation Analysis (0)]
23.  Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129-140.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 386]  [Cited by in F6Publishing: 447]  [Article Influence: 40.6]  [Reference Citation Analysis (1)]
24.  Zhang J, Qiao QL, Guo XC, Zhao JX. Application of three-dimensional visualization technique in preoperative planning of progressive hilar cholangiocarcinoma. Am J Transl Res. 2018;10:1730-1735.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Okuda Y, Taura K, Seo S, Yasuchika K, Nitta T, Ogawa K, Hatano E, Uemoto S. Usefulness of operative planning based on 3-dimensional CT cholangiography for biliary malignancies. Surgery. 2015;158:1261-1271.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 21]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
26.  Xiang N, Fang C, Fan Y, Yang J, Zeng N, Liu J, Zhu W. Application of liver three-dimensional printing in hepatectomy for complex massive hepatocarcinoma with rare variations of portal vein: preliminary experience. Int J Clin Exp Med. 2015;8:18873-18878.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Uchida M. Recent advances in 3D computed tomography techniques for simulation and navigation in hepatobiliary pancreatic surgery. J Hepatobiliary Pancreat Sci. 2014;21:239-245.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
28.  Cai W, Fan Y, Hu H, Xiang N, Fang C, Jia F. Postoperative liver volume was accurately predicted by a medical image three dimensional visualization system in hepatectomy for liver cancer. Surg Oncol. 2017;26:188-194.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 20]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
29.  Mutter D, Dallemagne B, Bailey Ch, Soler L, Marescaux J. 3D virtual reality and selective vascular control for laparoscopic left hepatic lobectomy. Surg Endosc. 2009;23:432-435.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 36]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
30.  Mise Y, Hasegawa K, Satou S, Shindoh J, Miki K, Akamatsu N, Arita J, Kaneko J, Sakamoto Y, Kokudo N. How Has Virtual Hepatectomy Changed the Practice of Liver Surgery? Ann Surg. 2018;268:127-133.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 66]  [Article Influence: 13.2]  [Reference Citation Analysis (3)]
31.  Miyamoto R, Oshiro Y, Nakayama K, Kohno K, Hashimoto S, Fukunaga K, Oda T, Ohkohchi N. Three-dimensional simulation of pancreatic surgery showing the size and location of the main pancreatic duct. Surg Today. 2017;47:357-364.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 24]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
32.  Fang CH, Kong D, Wang X, Wang H, Xiang N, Fan Y, Yang J, Zhong SZ. Three-dimensional reconstruction of the peripancreatic vascular system based on computed tomographic angiography images and its clinical application in the surgical management of pancreatic tumors. Pancreas. 2014;43:389-395.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 27]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
33.  Fang CH, Zhu W, Wang H, Xiang N, Fan Y, Yang J, Wang X, Zhong Sz. A new approach for evaluating the resectability of pancreatic and periampullary neoplasms. Pancreatology. 2012;12:364-371.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 18]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
34.  Zein NN, Hanouneh IA, Bishop PD, Samaan M, Eghtesad B, Quintini C, Miller C, Yerian L, Klatte R. Three-dimensional print of a liver for preoperative planning in living donor liver transplantation. Liver Transpl. 2013;19:1304-1310.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 196]  [Cited by in F6Publishing: 178]  [Article Influence: 16.2]  [Reference Citation Analysis (0)]
35.  Fang C, Fang Z, Fan Y, Li J, Xiang F, Tao H. [Application of 3D visualization, 3D printing and 3D laparoscopy in the diagnosis and surgical treatment of hepatic tumors]. Nanfang Yikedaxue Xuebao. 2015;35:639-645.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Igami T, Nakamura Y, Hirose T, Ebata T, Yokoyama Y, Sugawara G, Mizuno T, Mori K, Nagino M. Application of a three-dimensional print of a liver in hepatectomy for small tumors invisible by intraoperative ultrasonography: preliminary experience. World J Surg. 2014;38:3163-3166.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 77]  [Article Influence: 8.6]  [Reference Citation Analysis (0)]
37.  Igami T, Nakamura Y, Oda M, Tanaka H, Nojiri M, Ebata T, Yokoyama Y, Sugawara G, Mizuno T, Yamaguchi J, Mori K, Nagino M. Application of three-dimensional print in minor hepatectomy following liver partition between anterior and posterior sectors. ANZ J Surg. 2018;88:882-885.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
38.  Burdall OC, Makin E, Davenport M, Ade-Ajayi N. 3D printing to simulate laparoscopic choledochal surgery. J Pediatr Surg. 2016;51:828-831.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 32]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
39.  Soejima Y, Taguchi T, Sugimoto M, Hayashida M, Yoshizumi T, Ikegami T, Uchiyama H, Shirabe K, Maehara Y. Three-dimensional printing and biotexture modeling for preoperative simulation in living donor liver transplantation for small infants. Liver Transpl. 2016;22:1610-1614.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 27]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
40.  Watson RA. A low-cost surgical application of additive fabrication. J Surg Educ. 2014;71:14-17.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 62]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
41.  Javan R, Herrin D, Tangestanipoor A. Understanding Spatially Complex Segmental and Branch Anatomy Using 3D Printing: Liver, Lung, Prostate, Coronary Arteries, and Circle of Willis. Acad Radiol. 2016;23:1183-1189.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 54]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
42.  Faulkner-Jones A, Fyfe C, Cornelissen DJ, Gardner J, King J, Courtney A, Shu W. Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D. Biofabrication. 2015;7:044102.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 287]  [Cited by in F6Publishing: 300]  [Article Influence: 33.3]  [Reference Citation Analysis (0)]
43.  Sauer IM, Queisner M, Tang P, Moosburner S, Hoepfner O, Horner R, Lohmann R, Pratschke J. Mixed Reality in Visceral Surgery: Development of a Suitable Workflow and Evaluation of Intraoperative Use-cases. Ann Surg. 2017;266:706-712.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 80]  [Article Influence: 11.4]  [Reference Citation Analysis (0)]
44.  Okamoto T, Onda S, Matsumoto M, Gocho T, Futagawa Y, Fujioka S, Yanaga K, Suzuki N, Hattori A. Utility of augmented reality system in hepatobiliary surgery. J Hepatobiliary Pancreat Sci. 2013;20:249-253.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 28]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
45.  Abe Y, Itano O, Kitago M, Shinoda M, Yagi H, Hibi T, Takano K, Chiba N, Kawachi S, Shimazu M, Kitagawa Y. Computer assisted surgery, preoperative planning and navigation for pancreatic cancer. J Hepatobiliary Pancreat Sci. 2014;21:251-255.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
46.  Okamoto T, Onda S, Yasuda J, Yanaga K, Suzuki N, Hattori A. Navigation surgery using an augmented reality for pancreatectomy. Dig Surg. 2015;32:117-123.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 25]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
47.  Sugimoto M, Yasuda H, Koda K, Suzuki M, Yamazaki M, Tezuka T, Kosugi C, Higuchi R, Watayo Y, Yagawa Y, Uemura S, Tsuchiya H, Azuma T. Image overlay navigation by markerless surface registration in gastrointestinal, hepatobiliary and pancreatic surgery. J Hepatobiliary Pancreat Sci. 2010;17:629-636.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 80]  [Cited by in F6Publishing: 50]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
48.  Onda S, Okamoto T, Kanehira M, Fujioka S, Suzuki N, Hattori A, Yanaga K. Short rigid scope and stereo-scope designed specifically for open abdominal navigation surgery: clinical application for hepatobiliary and pancreatic surgery. J Hepatobiliary Pancreat Sci. 2013;20:448-453.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 24]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
49.  Ntourakis D, Memeo R, Soler L, Marescaux J, Mutter D, Pessaux P. Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience. World J Surg. 2016;40:419-426.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 58]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
50.  Tokuyasu T, Iwashita Y, Matsunobu Y, Kamiyama T, Ishikake M, Sakaguchi S, Ebe K, Tada K, Endo Y, Etoh T, Nakashima M, Inomata M. Development of an artificial intelligence system using deep learning to indicate anatomical landmarks during laparoscopic cholecystectomy. Surg Endosc. 2020;.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 35]  [Article Influence: 8.8]  [Reference Citation Analysis (0)]
51.  Yoon YI, Kim KH, Cho HD, Kwon JH, Jung DH, Park GC, Song GW, Ha TY, Lee SG. Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study. Surg Endosc. 2020;34:796-805.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 8]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
52.  Nicolau S, Soler L, Mutter D, Marescaux J. Augmented reality in laparoscopic surgical oncology. Surg Oncol. 2011;20:189-201.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 269]  [Cited by in F6Publishing: 178]  [Article Influence: 13.7]  [Reference Citation Analysis (0)]
53.  Bichlmeier C, Heining SM, Feuerstein M, Navab N. The virtual mirror: a new interaction paradigm for augmented reality environments. IEEE Trans Med Imaging. 2009;28:1498-1510.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 29]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
54.  Li L, Yu F, Shi D, Shi J, Tian Z, Yang J, Wang X, Jiang Q. Application of virtual reality technology in clinical medicine. Am J Transl Res. 2017;9:3867-3880.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Phutane P, Buc E, Poirot K, Ozgur E, Pezet D, Bartoli A, Le Roy B. Preliminary trial of augmented reality performed on a laparoscopic left hepatectomy. Surg Endosc. 2018;32:514-515.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 17]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
56.  Hallet J, Soler L, Diana M, Mutter D, Baumert TF, Habersetzer F, Marescaux J, Pessaux P. Trans-thoracic minimally invasive liver resection guided by augmented reality. J Am Coll Surg. 2015;220:e55-e60.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 42]  [Article Influence: 4.7]  [Reference Citation Analysis (0)]
57.  Sinha RY, Raje SR, Rao GA. Three-dimensional laparoscopy: Principles and practice. J Minim Access Surg. 2017;13:165-169.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 17]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
58.  De Paolis LT, De Luca V. Augmented visualization with depth perception cues to improve the surgeon's performance in minimally invasive surgery. Med Biol Eng Comput. 2019;57:995-1013.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 17]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
59.  Tang R, Ma LF, Rong ZX, Li MD, Zeng JP, Wang XD, Liao HE, Dong JH. Augmented reality technology for preoperative planning and intraoperative navigation during hepatobiliary surgery: A review of current methods. Hepatobiliary Pancreat Dis Int. 2018;17:101-112.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 61]  [Cited by in F6Publishing: 61]  [Article Influence: 10.2]  [Reference Citation Analysis (0)]
60.  Kowalewski KF, Garrow CR, Proctor T, Preukschas AA, Friedrich M, Müller PC, Kenngott HG, Fischer L, Müller-Stich BP, Nickel F. LapTrain: multi-modality training curriculum for laparoscopic cholecystectomy-results of a randomized controlled trial. Surg Endosc. 2018;32:3830-3838.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 27]  [Cited by in F6Publishing: 29]  [Article Influence: 4.8]  [Reference Citation Analysis (0)]
61.  Kang CM, Kim DH, Lee WJ, Chi HS. Conventional laparoscopic and robot-assisted spleen-preserving pancreatectomy: does da Vinci have clinical advantages? Surg Endosc. 2011;25:2004-2009.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 147]  [Cited by in F6Publishing: 153]  [Article Influence: 10.9]  [Reference Citation Analysis (0)]
62.  Giulianotti PC, Sbrana F, Bianco FM, Elli EF, Shah G, Addeo P, Caravaglios G, Coratti A. Robot-assisted laparoscopic pancreatic surgery: single-surgeon experience. Surg Endosc. 2010;24:1646-1657.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 276]  [Cited by in F6Publishing: 261]  [Article Influence: 18.6]  [Reference Citation Analysis (0)]
63.  Tsung A, Geller DA, Sukato DC, Sabbaghian S, Tohme S, Steel J, Marsh W, Reddy SK, Bartlett DL. Robotic versus laparoscopic hepatectomy: a matched comparison. Ann Surg. 2014;259:549-555.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 220]  [Cited by in F6Publishing: 238]  [Article Influence: 23.8]  [Reference Citation Analysis (0)]
64.  Pessaux P, Diana M, Soler L, Piardi T, Mutter D, Marescaux J. Towards cybernetic surgery: robotic and augmented reality-assisted liver segmentectomy. Langenbecks Arch Surg. 2015;400:381-385.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 103]  [Cited by in F6Publishing: 89]  [Article Influence: 8.9]  [Reference Citation Analysis (0)]
65.  Buchs NC, Volonte F, Pugin F, Toso C, Fusaglia M, Gavaghan K, Majno PE, Peterhans M, Weber S, Morel P. Augmented environments for the targeting of hepatic lesions during image-guided robotic liver surgery. J Surg Res. 2013;184:825-831.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 41]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
66.  Hu Y, Zhang L, Li W, Yang GZ.   Robotic sewing and knot tying for personalized stent graft manufacturing. In 2018 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS); 2018 Oct 1; Madrid, Spain. IEEE, 2019: 754-760.  [PubMed]  [DOI]  [Cited in This Article: ]
67.  Marcus HJ, Pratt P, Hughes-Hallett A, Cundy TP, Marcus AP, Yang GZ, Darzi A, Nandi D. Comparative effectiveness and safety of image guidance systems in neurosurgery: a preclinical randomized study. J Neurosurg. 2015;123:307-313.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 24]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
68.  Katić D, Spengler P, Bodenstedt S, Castrillon-Oberndorfer G, Seeberger R, Hoffmann J, Dillmann R, Speidel S. A system for context-aware intraoperative augmented reality in dental implant surgery. Int J Comput Assist Radiol Surg. 2015;10:101-108.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 40]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
69.  Kang X, Azizian M, Wilson E, Wu K, Martin AD, Kane TD, Peters CA, Cleary K, Shekhar R. Stereoscopic augmented reality for laparoscopic surgery. Surg Endosc. 2014;28:2227-2235.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 60]  [Cited by in F6Publishing: 51]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
70.  Miura F, Yamamoto M, Gotoh M, Konno H, Fujimoto J, Yanaga K, Kokudo N, Yamaue H, Wakabayashi G, Seto Y, Unno M, Miyata H, Hirahara N, Miyazaki M. Validation of the board certification system for expert surgeons (hepato-biliary-pancreatic field) using the data of the National Clinical Database of Japan: part 1 - Hepatectomy of more than one segment. J Hepatobiliary Pancreat Sci. 2016;23:313-323.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 34]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
71.  Merath K, Hyer JM, Mehta R, Farooq A, Bagante F, Sahara K, Tsilimigras DI, Beal E, Paredes AZ, Wu L, Ejaz A, Pawlik TM. Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery. J Gastrointest Surg. 2020;24:1843-1851.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 39]  [Cited by in F6Publishing: 67]  [Article Influence: 16.8]  [Reference Citation Analysis (0)]
72.  Jeong WK, Jamshidi N, Felker ER, Raman SS, Lu DS. Radiomics and radiogenomics of primary liver cancers. Clin Mol Hepatol. 2019;25:21-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 37]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
73.  Mai RY, Lu HZ, Bai T, Liang R, Lin Y, Ma L, Xiang BD, Wu GB, Li LQ, Ye JZ. Artificial neural network model for preoperative prediction of severe liver failure after hemihepatectomy in patients with hepatocellular carcinoma. Surgery. 2020;168:643-652.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 13]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
74.  Wingfield LR, Ceresa C, Thorogood S, Fleuriot J, Knight S. Using Artificial Intelligence for Predicting Survival of Individual Grafts in Liver Transplantation: A Systematic Review. Liver Transpl. 2020;26:922-934.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 24]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
75.  Liu CL, Soong RS, Lee WC, Jiang GW, Lin YC. Predicting Short-term Survival after Liver Transplantation using Machine Learning. Sci Rep. 2020;10:5654.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 17]  [Article Influence: 4.3]  [Reference Citation Analysis (0)]
76.  Koçak B, Durmaz EŞ, Ateş E, Kılıçkesmez Ö. Radiomics with artificial intelligence: a practical guide for beginners. Diagn Interv Radiol. 2019;25:485-495.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 109]  [Cited by in F6Publishing: 190]  [Article Influence: 47.5]  [Reference Citation Analysis (0)]
77.  Park HJ, Lee SS, Park B, Yun J, Sung YS, Shim WH, Shin YM, Kim SY, Lee SJ, Lee MG. Radiomics Analysis of Gadoxetic Acid-enhanced MRI for Staging Liver Fibrosis. Radiology. 2019;290:380-387.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 58]  [Cited by in F6Publishing: 90]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
78.  Liu F, Ning Z, Liu Y, Liu D, Tian J, Luo H, An W, Huang Y, Zou J, Liu C, Liu C, Wang L, Liu Z, Qi R, Zuo C, Zhang Q, Wang J, Zhao D, Duan Y, Peng B, Qi X, Zhang Y, Yang Y, Hou J, Dong J, Li Z, Ding H, Zhang Y, Qi X. Development and validation of a radiomics signature for clinically significant portal hypertension in cirrhosis (CHESS1701): a prospective multicenter study. EBioMedicine. 2018;36:151-158.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 56]  [Article Influence: 9.3]  [Reference Citation Analysis (0)]
79.  Tabrizian P, Jibara G, Shrager B, Schwartz M, Roayaie S. Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg. 2015;261:947-955.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 345]  [Cited by in F6Publishing: 384]  [Article Influence: 42.7]  [Reference Citation Analysis (0)]
80.  Zhou Y, He L, Huang Y, Chen S, Wu P, Ye W, Liu Z, Liang C. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol (NY). 2017;42:1695-1704.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 128]  [Cited by in F6Publishing: 151]  [Article Influence: 21.6]  [Reference Citation Analysis (0)]
81.  Lim KC, Chow PK, Allen JC, Chia GS, Lim M, Cheow PC, Chung AY, Ooi LL, Tan SB. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg. 2011;254:108-113.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 284]  [Cited by in F6Publishing: 313]  [Article Influence: 24.1]  [Reference Citation Analysis (0)]
82.  Banerjee S, Wang DS, Kim HJ, Sirlin CB, Chan MG, Korn RL, Rutman AM, Siripongsakun S, Lu D, Imanbayev G, Kuo MD. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma. Hepatology. 2015;62:792-800.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 203]  [Cited by in F6Publishing: 258]  [Article Influence: 28.7]  [Reference Citation Analysis (0)]
83.  Zheng BH, Liu LZ, Zhang ZZ, Shi JY, Dong LQ, Tian LY, Ding ZB, Ji Y, Rao SX, Zhou J, Fan J, Wang XY, Gao Q. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients. BMC Cancer. 2018;18:1148.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 97]  [Article Influence: 16.2]  [Reference Citation Analysis (0)]
84.  Sala Elarre P, Oyaga-Iriarte E, Yu KH, Baudin V, Arbea Moreno L, Carranza O, Chopitea Ortega A, Ponz-Sarvise M, Mejías Sosa LD, Rotellar Sastre F, Larrea Leoz B, Iragorri Barberena Y, Subtil Iñigo JC, Benito Boíllos A, Pardo F, Rodríguez Rodríguez J. Use of Machine-Learning Algorithms in Intensified Preoperative Therapy of Pancreatic Cancer to Predict Individual Risk of Relapse. Cancers (Basel). 2019;11.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]